Department of Neurosurgery, University of California San Francisco, 505 Parnassus Avenue, Room M779, Box 0112, San Francisco, CA 94143, USA.
Department of Neurosurgery, University of California San Francisco, 505 Parnassus Avenue, Room M779, Box 0112, San Francisco, CA 94143, USA.
J Clin Neurosci. 2020 Oct;80:282-289. doi: 10.1016/j.jocn.2020.08.007. Epub 2020 Oct 2.
Coccidioidomycosis exposure is common in the southwest United States and northern Mexico. Dissemination to the meninges is the most severe form of progression. Although ischemic strokes are well-reported in these patients, other cerebrovascular complications of coccidioidomycosis meningitis (CM), as well as their treatment options and outcomes, have not been systematically studied. We present a uniquely severe case of CM with several cerebrovascular complications. We also systematically queried PubMed and EMBASE databases, including articles published before April 2020 reporting human patients with CM-induced cerebrovascular pathology other than ischemic infarcts. Sixteen articles met inclusion criteria, which describe 6 patients with aneurysmal hemorrhage, 10 with non-aneurysmal hemorrhage, one with vasospasm, and one with transient ischemic attacks. CM-associated aneurysms invariably presented with hemorrhage. These were universally fatal until the past decade, when advances in surgical clipping and/or combined surgical and endovascular treatment have improved outcomes. We found that non-aneurysmal intracranial hemorrhages were limited to male patients, involved a diverse set of intracranial vasculature, and had a mortality rate surpassing 80%. Vasospasm was reported once, and was treated with percutaneous transluminal angioplasty. Transient ischemic attacks were reported once, and were successfully treated with fluconazole and dexamethasone. This review suggests that CM can present with a wide array of cerebrovascular complications, including ischemic infarcts, aneurysmogenesis, non-aneurysmal intracranial hemorrhage, vasospasm, and transient ischemic attacks. Mortality has improved over time due to advances in surgical and endovascular treatment modalities. The exception is non-aneurysmal intracranial hemorrhage, which remains associated with high mortality rates and few targeted therapeutic options.
球孢子菌病的暴露在美国西南部和墨西哥北部很常见。播散至脑膜是最严重的进展形式。尽管这些患者中缺血性中风的报道很多,但球孢子菌性脑膜炎(CM)的其他脑血管并发症及其治疗选择和结局尚未得到系统研究。我们报告了一例伴有多种脑血管并发症的 CM 极为严重的病例。我们还系统地检索了 PubMed 和 EMBASE 数据库,包括 2020 年 4 月之前发表的报告 CM 引起的除缺血性梗死以外的脑血管病变的人类患者的文章。符合纳入标准的有 16 篇文章,描述了 6 例伴有动脉瘤性出血、10 例非动脉瘤性出血、1 例血管痉挛和 1 例短暂性脑缺血发作的患者。CM 相关的动脉瘤无一例外地表现为出血。直到过去十年,随着手术夹闭和/或联合手术和血管内治疗的进步,这些动脉瘤才开始得到根治,在此之前,这些动脉瘤均是致命的。我们发现,非动脉瘤性颅内出血仅限于男性患者,涉及多种颅内血管,死亡率超过 80%。血管痉挛仅报告过一次,采用经皮腔内血管成形术治疗。短暂性脑缺血发作也仅报告过一次,采用氟康唑和地塞米松治疗。本综述表明,CM 可引起多种脑血管并发症,包括缺血性梗死、动脉瘤形成、非动脉瘤性颅内出血、血管痉挛和短暂性脑缺血发作。由于手术和血管内治疗方式的进步,死亡率随时间推移而改善。非动脉瘤性颅内出血是例外,其仍与高死亡率和有限的靶向治疗选择相关。